These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2927580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H.
    Bhargava HN, Gulati A, Ramarao P.
    Biochem Pharmacol; 1991 Jun 21; 42(1):25-9. PubMed ID: 1648922
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Normotensive Wistar rats differ from spontaneously hypertensive and renal hypertensive rats in their cardiovascular responses to opioid agonists.
    Widy-Tyszkiewicz E, Członkowski A.
    Clin Exp Pharmacol Physiol; 1991 Dec 21; 18(12):797-806. PubMed ID: 1797445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanisms involved in the hypotensive effect of a kappa-opioid receptor agonist in hypertensive rats.
    Guo HT, Zhang RH, Huang LY, Li J, Liu YL, Bi H, Zhang QY, Wang YM, Sun X, Ma XL, Cheng L, Liu JC, Yu SQ, Yi DH, Pei JM.
    Arch Med Res; 2007 Oct 21; 38(7):723-9. PubMed ID: 17845890
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of rat brain kappa 1- and kappa 2-opioid receptors after chronic treatment with non-peptide kappa-agonists.
    McConnaughey MM, Zhai QZ, Ingenito AJ.
    J Pharm Pharmacol; 1998 Oct 21; 50(10):1121-5. PubMed ID: 9821658
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK, Penz WP, Walker MJ, Wong TM.
    Br J Pharmacol; 1992 Mar 21; 105(3):521-6. PubMed ID: 1320979
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ventral tegmental injections of morphine but not U-50,488H enhance feeding in food-deprived rats.
    Noel MB, Wise RA.
    Brain Res; 1993 Dec 31; 632(1-2):68-73. PubMed ID: 8149246
    [Abstract] [Full Text] [Related]

  • 18. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T, Ohno M, Ueki S.
    Eur J Pharmacol; 1988 Oct 26; 156(1):173-6. PubMed ID: 2850208
    [Abstract] [Full Text] [Related]

  • 19. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads.
    Jackson A, Cooper SJ.
    Brain Res Bull; 1985 Oct 26; 15(4):391-6. PubMed ID: 2998563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.